Skip Navigation


Rheumatology Advance Access originally published online on August 1, 2008
Rheumatology 2008 47(10):1591; doi:10.1093/rheumatology/ken322
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/10/1591    most recent
ken322v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bhalla, A. K.
Right arrow Articles by Samaranayaka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhalla, A. K.
Right arrow Articles by Samaranayaka, M.
Related Collections
Right arrow Rehabilitation
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists

A. K. Bhalla1 and M. Samaranayaka1

1Royal National Hospital for Rheumatological Diseases, Bath, UK

Correspondence to: M. Samaranayaka, Royal National Hospital for Rheumatological Diseases, Upper Borough Walls, Bath BA1 1RL, UK. E-mail: samaranayaka2002@yahoo.co.uk

The first 10% of the full text of this article appears below.

SIR, We welcome the collective efforts of Dr Chakravarty and colleagues [1] in producing current revised guidelines on the DMARD therapy in consultation . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
K. Chakravarty
Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists: reply
Rheumatology, October 1, 2008; 47(10): 1591 - 1591.
[Full Text] [PDF]